Supplemental Table 3 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR&lt;sup&gt;+&lt;/sup&gt;/HER2&lt;sup&gt;−&lt;/sup&gt; Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7